Figure 1.
Flow charts for dapagliflozin versus other glucose‐lowering drug (GLD) groups. Proportions not fulfilling propensity‐matching 1:3 with 0.2 caliper were excluded and shown in grey boxes
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.